GSK taps Covance for clinical trials tech

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/everythingpossible)
(Image: Getty/everythingpossible)
LabCorp’s Covance Drug Development business has entered into a strategic technology agreement with GlaxoSmithKline plc (GSK) through which the company will use several of the CRO’s software solutions.

As per the agreement, GSK will use Covance’s Xcellerate Monitoring, Xcellerate Insights, and Xcellerate Clinical Data Hub solutions.

The Princeton, NJ-based contact research organization (CRO) will support GSK with implementation beginning in the first half of 2018.

Dimitris Agrafiotis, PhD, chief data officer and head of Technology Products at Covance, told us the company is excited to collaborate with GSK in the software-as-a-service (SaaS) model.

The Xcellerate Monitoring solution offers an objective, data-driven approach to clinical-trial monitoring that enables proactive identification and mitigation of risk at the study, site and subject level to safeguard patient safety, improve data quality, increase operational efficiency, and enable full transparency and oversight of study conduct and performance​,” he explained.

The solution uses adaptive central-monitoring methodology to enable sponsors to guide site monitoring resources to the sites that need the most attention, Agrafiotis said.

These capabilities are enabled by a state-of-the-art clinical data integration layer that provides timely, secure, integrated, and contextualized access to all clinical trial data through a unique user experience​,” he added.


Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more